Position in PFE
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,626,340,367
-$321,060,743 QoQ
Shares Held
109,067,291
+3.9% QoQ
Ownership
1.91%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#6
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fisher Asset Management, LLC holds $27,351,121,983 across 14 Drug Manufacturers - General names. PFE ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,063,516 | $6,073,333,502 | |
| 2 | MRK |
Merck & Co., Inc.
|
38,516,263 | $4,949,339,795 | |
| 3 | JNJ |
Johnson & Johnson
|
13,307,056 | $3,379,593,012 | |
| 4 | PFE |
Pfizer Inc
This page
|
109,067,291 | $2,626,340,367 | |
| 5 | NVS |
Novartis AG
|
15,523,378 | $2,432,823,800 | |
| 6 | ABBV |
AbbVie Inc.
|
9,497,970 | $2,390,069,170 | |
| 7 | AZN |
Astrazeneca PLC
|
11,146,292 | $2,113,559,889 | |
| 8 | GSK |
GSK plc
|
35,722,792 | $1,872,588,756 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,626,340,367 | 109,067,291 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $2,947,401,110 | 104,964,427 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,293,607,439 | 51,952,106 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,255,859,615 | 49,288,054 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,172,980,096 | 48,390,268 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,202,130,334 | 47,440,029 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $295,759,517 | 11,148,116 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $179,714,708 | 6,209,907 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $53,185,251 | 1,900,831 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $52,814,493 | 1,903,225 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $54,336,432 | 1,887,337 | Shares | Defined | 2024-03-05 | |
| 2023-09-30 | $64,142,819 | 1,933,760 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $70,580,499 | 1,924,223 | Shares | Sole | 2023-12-12 | |
| 2023-03-31 | $78,489,408 | 1,923,760 | Shares | Sole | 2023-12-12 | |
| 2022-12-31 | $100,212,271 | 1,955,743 | Shares | Defined | 2023-02-03 | |
| 2022-09-30 | $89,948,154 | 2,055,488 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $129,002,546 | 2,460,472 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $128,021,567 | 2,472,891 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $148,071,299 | 2,507,558 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $105,129,170 | 2,444,296 | Shares | Defined | 2021-10-26 | |
| 2021-06-30 | $95,807,759 | 2,446,572 | Shares | Defined | 2021-07-27 | |
| 2021-03-31 | $90,044,810 | 2,485,366 | Shares | Defined | 2021-04-27 | |
| 2020-12-31 | $93,640,480 | 2,543,887 | Shares | Defined | 2021-01-29 | |
| 2020-09-30 | $86,980,455 | 2,370,042 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $80,192,778 | 2,452,376 | Shares | Defined | 2020-08-07 | |
| 2020-03-31 | $177,827,603 | 5,448,157 | Shares | Defined | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||